
Results
3
3 companies
MedinCell
Market Cap: €973.0m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€27.10
7D
-8.2%
1Y
69.0%
DBV Technologies
Market Cap: €843.9m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.85
7D
-1.5%
1Y
54.0%
ABIVAX Société Anonyme
Market Cap: €10.6b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€122.90
7D
-9.0%
1Y
1,628.6%